ABIONYX Reports Monthly Voting Rights and Share Data

ABIONYX Pharma, listed on Euronext Paris, Compartment C, has disclosed its monthly statement regarding the company's share capital. As of November 30, 2025, the number of shares outstanding stands at 34,931,012. The total gross voting rights are reported at 44,816,425, while the total net voting rights, which exclude suspended voting rights, amount to 44,600,800.

The gross voting rights, serving as a basis for threshold calculations under Article 223-11 of the AMF General Regulations, include all shares with attached voting rights. The net voting rights provide a view of exercisable rights during Shareholders' Meetings, aligning with the AMF's 2007 recommendations.